MapLight Therapeutics (MPLT) Income Statement (2024 - 2026)
Income Statement report data from Mar 31, 2024 to Mar 31, 2026 for MapLight Therapeutics (MPLT).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||
Research And Development | 54M (-41.31%) | 91M (+237.65%) | 27M | - | 20M (-61.73%) | 52M (+207.61%) | 17M | - | - |
Selling General And Administrative | 11M (-52.06%) | 23M (+412.95%) | 4.40M | - | 3.76M (-63.64%) | 10M (+153.43%) | 4.08M | - | - |
Operating Expenses | 65M (-43.44%) | 114M (+262.03%) | 32M | - | 24M (-62.06%) | 62M (+197.03%) | 21M | - | - |
Depreciation And Amortization | 160K (-48.39%) | 310K (+210.00%) | 100K | - | 170K (-66.00%) | 500K (+150.00%) | 200K | - | - |
Operating Income | |||||||||
Operating Income | -64.50M (-43.44%) | -114.04M (+262.03%) | -31.50M | - | -23.54M (-62.06%) | -62.05M (+197.03%) | -20.89M | - | - |
Ebit | -64.50M (-23.40%) | -84.20M (+167.30%) | -31.50M (+5.53%) | -29.85M (+26.81%) | -23.54M (-4.77%) | -24.72M (+18.33%) | -20.89M (+13.53%) | -18.40M (-2.80%) | -18.93M |
EBITDA | -64.34M (-23.30%) | -83.88M (+167.13%) | -31.40M (+5.19%) | -29.85M (+27.67%) | -23.38M (-3.47%) | -24.22M (+17.06%) | -20.69M (+12.45%) | -18.40M (-2.80%) | -18.93M |
Other Income / Expenses | |||||||||
Interest Income | 2.47M (-21.84%) | 3.16M (+103.87%) | 1.55M | - | 810K (-76.32%) | 3.42M (+216.67%) | 1.08M | - | - |
Net Interest Income | 2.47M (-21.84%) | 3.16M (+103.87%) | 1.55M | - | 810K (-76.32%) | 3.42M (+216.67%) | 1.08M | - | - |
Other Non Operating Income | 1.36M (-43.57%) | 2.41M (+354.72%) | 530K | - | 390K (-78.92%) | 1.85M (+131.25%) | 800K | - | - |
Net Income | |||||||||
Net Income From Continuing Operations | -60.67M (-23.73%) | -79.55M (+170.39%) | -29.42M (-1.44%) | -29.85M (+33.62%) | -22.34M (+5.23%) | -21.23M (+11.62%) | -19.02M (+3.37%) | -18.40M (-2.80%) | -18.93M |
Net Income | -60.67M (-23.73%) | -79.55M (+170.39%) | -29.42M (-1.44%) | -29.85M (+33.62%) | -22.34M (+5.23%) | -21.23M (+11.62%) | -19.02M (+3.37%) | -18.40M (-2.80%) | -18.93M |
Comprehensive Income Net Of Tax | -61.32M (-62.04%) | -161.54M (+449.08%) | -29.42M | - | -22.42M (-71.04%) | -77.42M (+320.76%) | -18.40M | - | - |